cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with uridine triphosphate in 1 studies
| Studies (cystic fibrosis transmembrane conductance regulator (505-511)) | Trials (cystic fibrosis transmembrane conductance regulator (505-511)) | Recent Studies (post-2010) (cystic fibrosis transmembrane conductance regulator (505-511)) | Studies (uridine triphosphate) | Trials (uridine triphosphate) | Recent Studies (post-2010) (uridine triphosphate) |
|---|---|---|---|---|---|
| 17 | 1 | 3 | 2,423 | 20 | 331 |
| Protein | Taxonomy | cystic fibrosis transmembrane conductance regulator (505-511) (IC50) | uridine triphosphate (IC50) |
|---|---|---|---|
| P2Y purinoceptor 2 | Mus musculus (house mouse) | 1.51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| König, J; Kunzelmann, K; Mall, M; Schreiber, R | 1 |
1 other study(ies) available for cystic fibrosis transmembrane conductance regulator (505-511) and uridine triphosphate
| Article | Year |
|---|---|
No evidence for inhibition of ENaC through CFTR-mediated release of ATP.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Amiloride; Animals; Colon; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cystic Fibrosis Transmembrane Conductance Regulator; Electric Conductivity; Enzyme Inhibitors; Epithelial Sodium Channels; In Vitro Techniques; Mice; Nucleoside-Diphosphate Kinase; Oocytes; Peptide Fragments; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Sodium Channels; Uridine Triphosphate; Xenopus | 2002 |